Skip to main content

Melanie Ruthrauff Levy


[email protected]



Melanie provides pragmatic and experienced counsel to public and private companies in a broad range of matters, including initial public offerings and other capital market transactions, fallen angel reverse mergers, corporate governance, public company reporting, mergers and acquisitions and other corporate transactional matters.

She regularly represents issuers and financing sources in the medical devices, life sciences and healthcare services industries.

Before joining Mintz, Melanie worked as a health care and science division legal associate for Thomson Reuters. In this position, she collaborated directly with data engineers and technology specialists in the design and implementation of solutions in response to the legislative and regulatory changes implemented by the Obama administration regarding health information exchanges, electronic medical records, and healthcare provider reporting and quality measures.


  • Represented life sciences companies in initial public offerings
  • Represented Evofem Biosciences, Inc. in its reverse merger with Neothetics, Inc.
  • Represented Mateon Therapeutics, Inc. in its reverse merger with Oncotelic, Inc.
  • Represented Dare Bioscience, Inc. in its reverse merger with Cerulean Pharma Inc.
  • Represented MabVax Therapeutics, Inc. in its reverse merger with Telik, Inc.
  • Represented software company in merger transaction with public company
  • Represented medical device company in cross border asset acquisition transaction with a Fortune 500 company
  • Represented medical device company in merger with Fortune 500 company
  • Represented medical software company in sale to large public software company
  • Represented professional services company in acquisition by private equity fund
  • Represented real estate finance company in merger with private company
  • Represented financial technology software company in multiple rounds of venture backed private placements
  • Represented medical device company in multiple venture backed private placements
  • Assisted numerous public life sciences companies in private and public follow on offerings
  • Represented venture fund in transactions with private battery and technology companies
  • Represented private semi-conductor company in multiple venture backed and private placement funding rounds
Read less


Public companies need to consider regulatory, legal, market, and ESG-related developments in preparing for their fiscal year-end filings with the SEC and their annual shareholder meetings. In an in-depth memorandum, Mintz attorneys discuss the SEC’s new cybersecurity disclosure rule, recent trends in reverse stock splits, and the SEC’s disclosure requirements for Rule 10b5-1 trading plans and insider trading policies, and other emerging issues affecting public companies.

Read more

In this special edition of the podcast, the team discusses lessons learned for board members from the failure of Silicon Valley Bank (SVB).

Read more

In our seventh session, the team is joined by Jeremy Glaser, Co-chair of our Venture Capital & Emerging Companies Practice, to discuss what you need to know about down round financings – overview; perceptions, implications, and risks; and how a board can best prepare for a down round.

Read more

In our sixth session, the team is joined by Jason Vigna, a Member in our Securities Litigation Practice, to discuss best practices for handling crises in the boardroom — including identifying, documenting, discussing, managing, and disclosing material risks.

Read more

With the conviction and 11-year sentence for former CEO Elizabeth Holmes, the team looks at the lessons to be learned from Theranos. The team discusses (1) the importance of open communication between board members and executives, (2) fostering a culture of compliance, and (3) tips for picking up on the early-warning signs.

Read more

In our fifth session, which focuses on employment law, the team is joined by Jen Rubin, a bicoastal Member in our Employment, Labor & Benefits Practice and Chair of our ESG Practice, to discuss best practices related to hiring an executive (hint: consensus is key), managing the executive at the board level, and how to (amicably) negotiate to terminate an executive.

Read more

In our fourth session, “ESG in the Boardroom,” the team is joined by Kristyn Noeth, Of Counsel at Mintz, to discuss best practices related to and practical implementation of ESG concepts, as well as the impending Climate Disclosure Rule. As noted in the introduction, fewer topics are generating more interest in boardrooms across the country (and at Mintz!) than environmental, social, and corporate governance.

Read more

In our third session, “Board Committees,” the team discusses the various types of committees, the role or purpose of committees, committee composition, ESG as it relates to committees, and board committee trends.

Read more

In our second session, “Running an Effective Board Meeting,” the team discusses key considerations for public and private companies in this critical area of governance.

Read more
Read less

News & Press

Press Release Thumbnail

Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.

News Thumbnail

Law360 featured the launch of the firm's Women's Health and Technology practice and highlighted founding Members Ellen JanosJoanne HawanaKaren Lovitch, and Melanie Levy.

Press Release Thumbnail

Mintz’s new Women’s Health and Technology Practice brings together attorneys from our transactional, intellectual property, health care, FDA regulatory, and litigation teams to serve FemTech and other life sciences clients. The practice advises companies, entrepreneurs, and investors focused on addressing unmet needs in women’s health.

Press Release Thumbnail

Best Lawyers® recognized 108 firm attorneys in the 2023 edition of The Best Lawyers in America©. Notably, two Mintz attorneys – Poonam Patidar and Scott M. Stanton – received 2023 “Lawyer of the Year” awards, and 28 firm attorneys were included in the inaugural edition of Best Lawyers: Ones to Watch.

Mintz lawyers represented Bio-Medical Devices, Inc. in the sale of a section of its manufacturing operations to Stryker Corporation, one of the world’s leading medical technology companies.
Attorneys from Mintz represented Workterra, a leading innovator in cloud-based benefits administration and talent management, in its sale to CareerBuilder. The purchase will significantly expand CareerBuilder’s product offering.
Read less

Events & Speaking


BIO International Convention

San Diego Convention Center

Conference Reference Image
Read less

Recognition & Awards

  • Best Lawyers of America Ones to Watch - Corporate Law (2021 - 2024)

  • State Bar of California Wiley W. Manuel Award, Pro Bono Legal Services

  • San Diego Volunteer Lawyer Program Distinguished Service Award

  • Order of the Coif

Read less